Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure

Pediatric Nephrology

Volumn 14, Issue 7, 2000, Pages 664-668

  Ardissino, Gianluigi ^a   Schmitt, Claus Peter ^b   Testa, Sara ^a   Claris Appiani, Aldo ^a   Mehls, Otto ^b  

^a Department of Pediatrics ^*  (Italy)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Chronic renal failure; Intermittent calcitriol; Pulse calcitriol; Secondary hyperparathyroidism

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE;

ADOLESCENT; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; MALE; MULTICENTER STUDY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM;

EID: 0034045940     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670000365     Document Type: Conference Paper

References (33)

1. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Shaiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43:436-442
2. Goodman WG, Coburn JW, Ramirez JA, Slatopolsky E, Salusky IB (1993) Primer on the metabolic bone diseases and disorders of mineral metabolism: renal osteodystrophy in adult and pediatric patients. Raven, New York, p 304
3. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ (1984) Marked suppression of hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143
4. Herrmann P, Ritz E, Schmidt-Gayk H, Schafer I, Geyer J, Nonnast-Daniel B, Koch KM, Weber U, Horl W, Haas-Worle A, Kuhn K, Bierther B, Schneider P (1994) Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial. Nephron 67:48-53
5. Silver J, Naveh-Many T, Mayer H, Schmeizer HJ, Popvtzer MM (1986) Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in rat. J Clin Invest 78:1296-1301
6. 2D3 of transcription of the pre-proparathyroid hormone gene. Endocrinology 119:2864-2866
7. Seidel A, Herrmann P, Klaus G, Mehls O, Schmidt-Gayk H, Ritz E (1993) Kinetics of serum 1,84 iPTH after high dose of calcitriol in uremic patients. Clin Nephrol 39:210-213
8. Klaus G, Schmidt-Gayk H, Roth HJ, Ritz E, Mehls O (1994) Single-dose oral calcitriol and changes of plasma iPTH in uremic children. Adv Perit Dial 10:261-266
9. Quarles LD, Yohay DA, Carrol BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA (1994) Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710-1721
10. Ficher ER, Harris DC (1993) Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol 40:216-220
11. Levine BS, Song M (1996) Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol 7:488-496
12. Salusky IB, Goodman W (1996) Skeletal response to intermittent calcitriol therapy in secondary hyperparathyroidism. Kidney Int 49: S135-S139
13. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166
14. Kuizon BD, Goodman WG, Juppner H, Boechat I, Nelson P, Gales B, Salusky I (1998) Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD. Kidney Int 53:205-211
15. Mehls O, Knöller N, Oh J, Wesch H, Wünsche B, Schmitt CP (2000) Daily but not pulse calcitriol therapy improves growth in experimental uremia. Pediatr Nephrol 14:658-663
16. Naveh-Many T, Sela-Brown A, Silver J (1999) Protein-RNA interaction in the regulation of PTH gene expression by calcium and phosphate. Nephrol Dial Transplant 14:811-813
17. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by iv 1,25 dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 83:1349-1355
18. Andress DL, Norris KC, Coburn JW, Slatopolsky EA, Sherrad DJ (1989) Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med 321:274-279
19. Ardissino G, Schmitt C, Claris-Appiani A, Daccò V, Mehls O (1997) Equal intestinal calcium absorption and greater PTH suppression with oral versus iv calcitriol bolus in children with secondary hyperparathyroidism (abstract). J Am Soc Nephrol 8:571
20. Reichel H, Szabo A, Uhl J, Pesian S, Schmutz A, Schmidt-Gayk H, Ritz E (1993) Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism. Kidney Int 44:1259-1265
21. Martin KJ, Sudarshan Ballal H, Domoto DT, Blalock S, Weindel M (1992) Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: preliminary observations. Am J Kidney Dis 19:540-545
22. Tsukamoto Y, Nomura M, Takahashi Y, Takagi Y, Yoshida A, Nagaoka T, Togashi K, Kikawada R, Marumo F (1991) The oral 1,25-clihydroxyvitamin D3 pulse therapy in hemodialysis patients with severe secondary hyperparathyroidism. Nephron 57:23-28
23. Perez-Mijares R, Gomez-Fernandez P, Almaraz-Jimenez M, Ramos-Diaz M, Rivero-Bohorquez J (1993) Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration. Am J Nephrol 13:149-154
24. Juergensen P, Finkelstein FO, Cooper K, Santacroce S, Kliger AS (1993) Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol. Adv Perit Dial 9:257-259
25. Juergensen P, Santacroce S, Mooraki A, Cooper K, Finkelstein FO, Kliger AS (1994) Pulse oral calcitriol to treat hyperparathyroidism in 43 CAPD patients. Adv Perit Dial 10:259-260
26. Romanini D, Gazo A, Bellazzi R, de Vincenzi A, Nai M, Santagostino M (1994) Long-term effect of oral calcitriol single weekly pulse in CAPD and in HD. Adv Perit Dial 10: 267-269
27. Scanziani R, Dozio B, Bonforte G, Surian M (1994) Effects of calcitriol pulse therapy per os in CAPD patients. Adv Perit Dial 10:270-274
28. Cano F, Delucchi A, Wolff E, Rodriguez E, Fuentes A (1995) Calcitriol oral pulse therapy in children with renal osteodystrophy. Pediatr Nephrol 9:606-608
29. Oettinger CW, Oliver JC, Macon EJ (1992) The effect of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients. J Am Soc Nephrol 3:995-1001
30. Panichi V, Andreini B, Bianchi AM, Parrini M, Ferdeghini M, Finato V, Giovannini L, Migliori M, De Pietro S, Palla R (1995) Calcitriol therapy in predialytic secondary hyperparathyroidism: effects of oral pulses versus a daily oral regimen. J Nephrol 8:206-209
31. Watanabe Y, Inaguma D, Fukuzawa Y, Kumon S, Yamazaki C (1996) Oral vitamin D3 pulse therapy for overt secondary hyperparathyroidism at pre-dialysis stage. Nephron Dial Transplant 11:910-911
32. Klaus G, Mehls O, Hinderer J, Ritz E (1991) Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism? Lancet 337:800-801
33. 2D3 effects in primary cultures of growth cartilage cells of rat. Calcif Tissue Int 49:340-348